多重检测市场规模、份额及成长分析（按产品类型、技术、应用、最终用户和地区）－2025 年至 2032 年产业预测

预计多重检测市场规模在 2023 年将达到 37 亿美元，并将从 2024 年的 40.5 亿美元增长到 2032 年的 83.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.5%。

由于慢性病和感染疾病的日益普及以及多重检测相对于传统方法的优势，全球多重检测市场正在经历显着成长。伴同性诊断的使用日益广泛，例如罗氏公司用于识别 dMMR固体癌的治疗药物已获得 FDA核准，表明该领域前景光明。早期诊断可使非小细胞肺癌等癌症的存活率提高三倍，进一步凸显了市场的扩张潜力。此外，生物标记检验和自动化系统的需求正在推动高通量检测的需求。多重检测广泛应用于癌症、自体免疫疾病和神经退化性疾病等，对于早期发现和提高认识至关重要，最终推动市场成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

多重检测市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概览
• 耗材
• 装置
• 软体

多重分析市场规模（按类型及复合年增长率） (2025-2032)

• 市场概览
• 蛋白质多重检测
  • 平面蛋白质测定
  • 以微珠为基础的蛋白质测定
  • 其他的
• 核酸多重检测
  • 平面核酸检测
  • 以微珠为基础的核酸检测
  • 其他的
• 基于细胞的多重分析

多重分析市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 流式细胞技术
• 萤光侦测
• 照明
• 多重即时PCR
• 其他的

多重分析市场规模（按应用和复合年增长率） (2025-2032)

• 市场概览
• 研究与开发
  • 药物研发
  • 生物标记的发现与检验
• 临床诊断
  • 感染疾病
  • 癌症
  • 心血管疾病
  • 自体免疫疾病
  • 神经系统疾病
  • 代谢和内分泌失调
  • 其他疾病

多重分析市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 製药和生物技术公司
• 医院和研究机构
• 参考实验室
• 其他的

多重分析市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Lonza Group（Switzerland）
• DiaSorin（Italy）
• WuXi Biologics（China）
• Seegene（South Korea）
• Ayoxxa Biosystems（Germany）
• Thermo Fisher Scientific（United States）
• Bio-Rad Laboratories（United States）
• Luminex Corporation（United States）
• QIAGEN（Germany）
• Illumina（United States）
• Agilent Technologies（United States）
• PerkinElmer（United States）
• Merck KGaA（Germany）
• Becton, Dickinson and Company（United States）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Danaher Corporation（United States）
• Abbott Laboratories（United States）
• Meso Scale Diagnostics（United States）
• Quanterix Corporation（United States）

结论和建议

Multiplex Assay Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.05 billion in 2024 to USD 8.37 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The global multiplex assay market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases and the advantages of multiplex assays over traditional methods. The rising utilization in companion diagnostics is particularly noteworthy, as evidenced by FDA approvals like Roche's for identifying dMMR solid tumors, indicating a promising future for this sector. Early disease diagnosis, which can triple survival rates for cancers such as non-small cell lung cancer, further emphasizes the market's expansion potential. Additionally, the validation of biomarkers and demand for automated systems bolster the need for high-throughput assays. With applications spanning cancer, autoimmune diseases, and neurodegenerative disorders, multiplex assays are pivotal in enhancing early detection and raising awareness, ultimately fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Multiplex Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Multiplex Assay Market Segments Analysis

Global Multiplex Assay Market is segmented by Product Type, Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software. Based on Type, the market is segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays and Cell-based Multiplex Assays. Based on Technology, the market is segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR and Others. Based on Application, the market is segmented into Research & Development and Clinical Diagnostics. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Multiplex Assay Market

The increasing emphasis on personalized medicine is significantly fueling the growth of the multiplex assay market. These assays facilitate the simultaneous analysis of several biomarkers, which enhances patient stratification and leads to more tailored treatment options. By enabling healthcare providers to assess multiple health indicators at once, multiplex assays contribute to more accurate diagnoses and effective therapeutic strategies. This capability not only optimizes patient care but also supports the shift towards individualized therapies that cater to specific patient needs, thus reinforcing the demand for these advanced diagnostic tools in clinical settings.

Restraints in the Multiplex Assay Market

The multiplex assay market faces significant restraints primarily due to regulatory challenges that can hinder their widespread adoption. The complex nature of these assays necessitates obtaining regulatory approval, a process that is often time-consuming and financially burdensome. Such stringent requirements can deter manufacturers from developing and introducing new multiplex assays into the market, ultimately slowing innovation and limiting the availability of these advanced diagnostic tools. Consequently, the lengthy regulatory procedures may restrict market growth and access to potentially valuable multiplex assays that could significantly enhance diagnostic accuracy and efficiency across various medical applications.

Market Trends of the Multiplex Assay Market

The multiplex assay market is witnessing a significant trend towards the adoption of multiplex immunoassays, driven by their efficiency in measuring multiple protein targets within a single sample. This capability not only streamlines workflows but also enhances the accuracy and throughput of diagnostic testing, drug discovery, and biomarker identification processes. As healthcare continues to shift towards personalized medicine and more precise diagnostics, the demand for these assays is expected to grow steadily. Furthermore, advancements in technology that facilitate higher sensitivity and multiplexing capabilities are propelling market growth, positioning multiplex immunoassays as essential tools in clinical research and therapeutics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Multiplex Assay Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments
• Software

Global Multiplex Assay Market Size by Type & CAGR (2025-2032)

• Market Overview
• Protein Multiplex Assays
  • Planar Protein Assays
  • Bead-based Protein Assays
  • Others
• Nucleic Acid Multiplex Assays
  • Planar Nucleic Acid Assays
  • Bead-based Nucleic Acid Assays
  • Others
• Cell-based Multiplex Assays

Global Multiplex Assay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Flow Cytometry
• Fluorescence Detection
• Luminescence
• Multiplex Real-time PCR
• Others

Global Multiplex Assay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research & Development
  • Drug Discovery & Development
  • Biomarker Discovery & Validation
• Clinical Diagnostics
  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Nervous System Disorders
  • Metabolism & Endocrinology Disorders
  • Other Diseases

Global Multiplex Assay Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Hospitals & Research Institutes
• Reference Laboratories
• Others

Global Multiplex Assay Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ayoxxa Biosystems (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meso Scale Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanterix Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations